Newly diagnosed multiple myeloma: current treatment strategies, emerging therapeutic approaches and beyond
Author:
Affiliation:
1. Department of Medicine, Division of Oncology, University of Maryland Medical Center, Baltimore, MD, USA
Publisher
Informa UK Limited
Subject
Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/17474086.2020.1756258
Reference81 articles.
1. The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2. The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
3. Lenalidomide enhances anti-myeloma cellular immunity
4. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
5. Thalidomide is an inhibitor of angiogenesis.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review;Frontiers in Pharmacology;2023-11-06
2. A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation;Transfusion Medicine and Hemotherapy;2023-10-16
3. Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment;European Journal of Medicinal Chemistry;2023-01
4. Anti CD38 monoclonal antibodies for multiple myeloma treatment;Human Vaccines & Immunotherapeutics;2022-04-11
5. The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan;Journal of Personalized Medicine;2022-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3